Literature DB >> 28911979

Opening Pandora's Box: Mechanisms of Mycobacterium tuberculosis Resuscitation.

Ashley V Veatch1, Deepak Kaushal2.   

Abstract

Mycobacterium tuberculosis (Mtb) characteristically causes an asymptomatic infection. While this latent tuberculosis infection (LTBI) is not contagious, reactivation to active tuberculosis disease (TB) causes the patient to become infectious. A vaccine has existed for TB for a century, while drug treatments have been available for over 70 years; despite this, TB remains a major global health crisis. Understanding the factors which allow the bacillus to control responses to host stress and mechanisms leading to latency are critical for persistence. Similarly, molecular switches which respond to reactivation are important. Recently, research in the field has sought to focus on reactivation, employing system-wide approaches and animal models. Here, we describe the current work that has been done to elucidate the mechanisms of reactivation and stop reactivation in its tracks.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28911979      PMCID: PMC5794633          DOI: 10.1016/j.tim.2017.08.001

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  96 in total

1.  An adjunctive therapeutic vaccine against reactivation and post-treatment relapse tuberculosis.

Authors:  Toshiko Miyata; Chan-Ick Cheigh; Nicola Casali; Amador Goodridge; Olivera Marjanovic; Lon V Kendall; Lee W Riley
Journal:  Vaccine       Date:  2011-11-08       Impact factor: 3.641

2.  Double- and monofunctional CD4⁺ and CD8⁺ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals.

Authors:  Susanna Commandeur; May Y Lin; Krista E van Meijgaarden; Annemieke H Friggen; Kees L M C Franken; Jan W Drijfhout; Gro E Korsvold; Fredrik Oftung; Annemieke Geluk; Tom H M Ottenhoff
Journal:  Eur J Immunol       Date:  2011-08-30       Impact factor: 5.532

3.  The structure of a resuscitation-promoting factor domain from Mycobacterium tuberculosis shows homology to lysozymes.

Authors:  Martin Cohen-Gonsaud; Philippe Barthe; Claire Bagnéris; Brian Henderson; John Ward; Christian Roumestand; Nicholas H Keep
Journal:  Nat Struct Mol Biol       Date:  2005-02-20       Impact factor: 15.369

4.  Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice.

Authors:  T V Radaeva; B V Nikonenko; V V Mischenko; M M Averbakh; A S Apt
Journal:  Tuberculosis (Edinb)       Date:  2004-12-31       Impact factor: 3.131

5.  DosS Is required for the complete virulence of mycobacterium tuberculosis in mice with classical granulomatous lesions.

Authors:  Uma S Gautam; Amanda McGillivray; Smriti Mehra; Peter J Didier; Cecily C Midkiff; Ryan S Kissee; Nadia A Golden; Xavier Alvarez; Tianhua Niu; Jyothi Rengarajan; David R Sherman; Deepak Kaushal
Journal:  Am J Respir Cell Mol Biol       Date:  2015-06       Impact factor: 6.914

6.  Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: a model for persistent organisms?

Authors:  Tobias Hampshire; Shamit Soneji; Joanna Bacon; Brian W James; Jason Hinds; Ken Laing; Richard A Stabler; Philip D Marsh; Philip D Butcher
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

7.  Functional genomics reveals extended roles of the Mycobacterium tuberculosis stress response factor sigmaH.

Authors:  Smriti Mehra; Deepak Kaushal
Journal:  J Bacteriol       Date:  2009-04-17       Impact factor: 3.490

8.  Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Patients with Tuberculosis.

Authors:  Melissa D Chengalroyen; Germar M Beukes; Bhavna G Gordhan; Elizabeth M Streicher; Gavin Churchyard; Richard Hafner; Robin Warren; Kennedy Otwombe; Neil Martinson; Bavesh D Kana
Journal:  Am J Respir Crit Care Med       Date:  2016-12-15       Impact factor: 21.405

9.  Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH.

Authors:  Deepak Kaushal; Benjamin G Schroeder; Sandeep Tyagi; Tetsuyuki Yoshimatsu; Cherise Scott; Chiew Ko; Liane Carpenter; Jyoti Mehrotra; Yukari C Manabe; Robert D Fleischmann; William R Bishai
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

10.  A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen.

Authors:  Chirajyoti Deb; Chang-Muk Lee; Vinod S Dubey; Jaiyanth Daniel; Bassam Abomoelak; Tatiana D Sirakova; Santosh Pawar; Linda Rogers; Pappachan E Kolattukudy
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

View more
  12 in total

1.  Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques.

Authors:  Taylor W Foreman; Allison N Bucşan; Smriti Mehra; Charles Peloquin; Lara A Doyle; Kasi Russell-Lodrigue; Neel R Gandhi; John Altman; Cheryl L Day; Joel D Ernst; Henry M Blumberg; Jyothi Rengarajan; Deepak Kaushal
Journal:  Am J Respir Crit Care Med       Date:  2020-02-15       Impact factor: 30.528

Review 2.  Lung epithelial cells interact with immune cells and bacteria to shape the microenvironment in tuberculosis.

Authors:  Simone A Joosten; Anne M van der Does; Amy M de Waal; Pieter S Hiemstra; Tom Hm Ottenhoff
Journal:  Thorax       Date:  2022-01-11       Impact factor: 9.139

Review 3.  Regulation of Three Virulence Strategies of Mycobacterium tuberculosis: A Success Story.

Authors:  Niels A Zondervan; Jesse C J van Dam; Peter J Schaap; Vitor A P Martins Dos Santos; Maria Suarez-Diez
Journal:  Int J Mol Sci       Date:  2018-01-24       Impact factor: 5.923

4.  Resuscitation of Dormant "Non-culturable" Mycobacterium tuberculosis Is Characterized by Immediate Transcriptional Burst.

Authors:  Elena G Salina; Artem S Grigorov; Oksana S Bychenko; Yulia V Skvortsova; Ilgar Z Mamedov; Tatyana L Azhikina; Arseny S Kaprelyants
Journal:  Front Cell Infect Microbiol       Date:  2019-07-30       Impact factor: 5.293

5.  A New Antisense Phosphoryl Guanidine Oligo-2'-O-Methylribonucleotide Penetrates Into Intracellular Mycobacteria and Suppresses Target Gene Expression.

Authors:  Yulia V Skvortsova; Elena G Salina; Ekaterina A Burakova; Oksana S Bychenko; Dmitry A Stetsenko; Tatyana L Azhikina
Journal:  Front Pharmacol       Date:  2019-09-19       Impact factor: 5.810

6.  WhiB4 Is Required for the Reactivation of Persistent Infection of Mycobacterium marinum in Zebrafish.

Authors:  Chen Lin; Yuting Tang; Yuchen Wang; Junli Zhang; Yeyu Li; Shuqin Xu; Bin Xia; Qiran Zhai; Yao Li; Lu Zhang; Jun Liu
Journal:  Microbiol Spectr       Date:  2022-03-10

Review 7.  Immune evasion and provocation by Mycobacterium tuberculosis.

Authors:  Pallavi Chandra; Steven J Grigsby; Jennifer A Philips
Journal:  Nat Rev Microbiol       Date:  2022-07-25       Impact factor: 78.297

8.  Hypoxia Is Not a Main Stress When Mycobacterium tuberculosis Is in a Dormancy-Like Long-Chain Fatty Acid Environment.

Authors:  Patricia Del Portillo; Lázaro García-Morales; María Carmen Menéndez; Juan Manuel Anzola; Juan Germán Rodríguez; Addy Cecilia Helguera-Repetto; Miguel A Ares; Rafael Prados-Rosales; Jorge A Gonzalez-Y-Merchand; María Jesús García
Journal:  Front Cell Infect Microbiol       Date:  2019-01-09       Impact factor: 5.293

9.  TNF-α antagonists differentially induce TGF-β1-dependent resuscitation of dormant-like Mycobacterium tuberculosis.

Authors:  Ainhoa Arbués; Dominique Brees; Salah-Dine Chibout; Todd Fox; Michael Kammüller; Damien Portevin
Journal:  PLoS Pathog       Date:  2020-02-18       Impact factor: 6.823

Review 10.  Targeting Non-Replicating Mycobacterium tuberculosis and Latent Infection: Alternatives and Perspectives (Mini-Review).

Authors:  Anna Egorova; Elena G Salina; Vadim Makarov
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.